Lung cancer: open trials in Latvia

3 open trials have a site in Latvia. Registry data; only the trial team decides who can take part.

NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Pauls Stradins Clinical University Hospital, Riga · Rigas Austrumu kliniska universitates slimnica SIA, Riga
Registry updated 2026-11-06
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Rigas Austrumu kliniska universitates slimnica SIA, Riga · Pauls Stradins Clinical University Hospital, Riga
Registry updated 2026-10-28
NCT06473870
Understanding Lung Cancer Related Risk Factors and Their Impact
Research · Biobizkaia Health Research Institute
Riga East University Hospital, Riga
Registry updated 2024-06-25

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)